← Scroll for more →
Palatin Technologies Inc (PTN)
Pharmaceutical Preparations
Latest Price
$7.23
Market Cap
$12.86M
TTM P/E
--
Earnings Yield
--
TTM Div Yield
--
P/B Ratio
1.21
Price at the 2026-11-06 close. Earnings yield is trailing 12-month earnings divided by price.
Business Summary
full summary →Palatin Technologies is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, with product candidates targeting diseases with significant unmet medical need and commercial potential.
Price
full chart →- 1-Year Change
- -43.21%
- 52-Week High
- $31.00
- 52-Week Low
- $4.51
Daily close, 2025-11-12 to 2026-11-06
Financials
financial statements →| Quarter ending | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Last 4 quarters |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $8.85M | $116,036 | $3.92M | -$4.05M | $8.83M |
| Operating margin | -- | -- | 52.7% | -6315.8% | -40.3% | -- | -98.2% |
| Net income | -$4.81M | -$2.23M | $4.68M | -$7.26M | -$1.43M | -$4.36M | -$8.38M |
| Net margin | -- | -- | 52.9% | -6260.0% | -36.5% | -- | -94.9% |
| Operating cash flow | -$5.35M | -$4.09M | -$1.62M | -$4.81M | -$4.42M | -$2.69M | -$13.53M |
| Free cash flow | -$5.35M | -$4.09M | -- | -- | -$4.46M | -$2.69M | -- |
Chart: revenue per quarter, Mar 2025 to Jun 2026. Hover over or tap a row to chart it.
Quarters ending Mar 2025 to Jun 2026, oldest first.
Revenue ($M)
Last 4 quarters $8.83M
$10M$0-$5M
0.00.08.80.13.9-4.1
Operating margin (%)
Last 4 quarters -98.2%
0%-8000%
----53-6K-40--
Net income ($M)
Last 4 quarters -$8.38M
$5M$0-$8M
-4.8-2.24.7-7.3-1.4-4.4
Net margin (%)
Last 4 quarters -94.9%
0%-8000%
----53-6K-37--
Operating cash flow ($M)
Last 4 quarters -$13.53M
$0-$6M
-5.4-4.1-1.6-4.8-4.4-2.7
Free cash flow ($M)
Last 4 quarters --
$0-$6M
-5.4-4.1-----4.5-2.7
Capital Structure
balance sheet →- Shares Outstanding
- 1.78M
- Total Debt
- --
- Long-term Debt
- --
- Long-term Debt / Capital
- --
- Cash
- $7.49M
- Current Assets
- $8.16M
- Current Liabilities
- $1.77M
Current position as of 2026-06-30.
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Driehaus Capital Management LLC | 166.7K | $1.0M | 9.37% | -- | 2026-06-30 |
| Jupiter Topco LLC | 140.0K | $1.0M | 7.87% | -- | 2026-06-30 |
| Logos Global Management LP | 130.0K | $1.0M | 7.31% | -10.0K | 2026-06-30 |
| RA Capital Management, L.P. | 62.1K | -- | 3.49% | -7.9K | 2026-06-30 |
| Balyasny Asset Management L.P. | 41.1K | -- | 2.31% | -59 | 2026-06-30 |
| Morgan Stanley | 27.3K | -- | 1.53% | -- | 2026-06-30 |
| Opaleye Management Inc. | 20.5K | -- | 1.15% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 19.4K | -- | 1.09% | +880 | 2026-06-30 |
| Vanguard Capital Management LLC | 18.9K | -- | 1.06% | -68 | 2026-06-30 |
| Miller Financial Services LLC | 15.0K | -- | 0.84% | +2.4K | 2026-06-30 |
Insider Transactions
all insider transactions →| Name | Title | Transaction | Shares | Price | Date |
|---|---|---|---|---|---|
| Wills Stephen T | Executive VP and CFO/COO | Tax Withholding | 94 | $14.34 | 2026-07-15 |
| Wills Stephen T | Executive VP and CFO/COO | Tax Withholding | 79 | $11.72 | 2026-07-15 |
| Wills Stephen T | Executive VP and CFO/COO | Tax Withholding | 22 | $11.77 | 2026-07-15 |
| Spana Carl | President and CEO | Tax Withholding | 142 | $14.34 | 2026-07-15 |
| Spana Carl | President and CEO | Tax Withholding | 119 | $11.72 | 2026-07-15 |